| Timothy L Chapman, MD | |
|
25882 Orchard Lake Rd, Suite L-5a, Farmington Hills, MI 48336-1292 | |
| (313) 530-3452 | |
| Not Available |
| Full Name | Timothy L Chapman |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 24 Years |
| Location | 25882 Orchard Lake Rd, Farmington Hills, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023056199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301076878 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hegira Health Inc | 3173429560 | 26 |
News Archive
An electronic nose could be used to diagnose obstructive sleep apnea syndrome, by detecting the presence of volatile organic molecules in the breath of a patient, research suggests.
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years, according to a new article in the Archives of Internal Medicine.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.
Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.
› Verified 5 days ago
| Entity Name | Hegira Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184684979 PECOS PAC ID: 3173429560 Enrollment ID: O20031208000753 |
News Archive
An electronic nose could be used to diagnose obstructive sleep apnea syndrome, by detecting the presence of volatile organic molecules in the breath of a patient, research suggests.
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years, according to a new article in the Archives of Internal Medicine.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.
Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.
› Verified 5 days ago
| Entity Name | Community Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609844976 PECOS PAC ID: 5799758942 Enrollment ID: O20040816001041 |
News Archive
An electronic nose could be used to diagnose obstructive sleep apnea syndrome, by detecting the presence of volatile organic molecules in the breath of a patient, research suggests.
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years, according to a new article in the Archives of Internal Medicine.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.
Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.
› Verified 5 days ago
| Entity Name | Trinity Health Connections Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003277229 PECOS PAC ID: 7315236338 Enrollment ID: O20160516000226 |
News Archive
An electronic nose could be used to diagnose obstructive sleep apnea syndrome, by detecting the presence of volatile organic molecules in the breath of a patient, research suggests.
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years, according to a new article in the Archives of Internal Medicine.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.
Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.
› Verified 5 days ago
| Entity Name | Mind Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376124925 PECOS PAC ID: 2466827647 Enrollment ID: O20230403000364 |
News Archive
An electronic nose could be used to diagnose obstructive sleep apnea syndrome, by detecting the presence of volatile organic molecules in the breath of a patient, research suggests.
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years, according to a new article in the Archives of Internal Medicine.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.
Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy L Chapman, MD Po Box 8171, Bloomfield Hills, MI 48302-8171 Ph: (248) 426-7299 | Timothy L Chapman, MD 25882 Orchard Lake Rd, Suite L-5a, Farmington Hills, MI 48336-1292 Ph: (313) 530-3452 |
News Archive
An electronic nose could be used to diagnose obstructive sleep apnea syndrome, by detecting the presence of volatile organic molecules in the breath of a patient, research suggests.
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years, according to a new article in the Archives of Internal Medicine.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.
Now in its 13th year of providing a voice for people who have kidney disease and are passionate about writing, Renal Support Network announces the winners of its 13th Annual Essay Contest.
› Verified 5 days ago
Katherine Elizabeth Ross, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-8399 | |
Paul Harold Finkel, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 28595 Orchard Lake Rd, Suite 200, Farmington Hills, MI 48334 Phone: 248-553-0010 Fax: 248-553-5957 | |
Alex Kaddis, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-8399 | |
Joshua Nass, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 28595 Orchard Lake Rd Ste 200, Farmington Hills, MI 48334 Phone: 248-553-0010 | |
Alexis Brimmeier, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-553-0010 | |
Amy Ishbia, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 28595 Orchard Lake Rd, Farmington Hills, MI 48334 Phone: 248-553-0010 |